13D Filing: OrbiMed Advisors and Intellia Therapeutics Inc (NTLA)

Carl L. Gordon (“Gordon”), a Member of Advisors, was a member of the Board of Directors of the Issuer from August 2015 until July 2017, and, accordingly, the Reporting Persons may have had the ability to affect and influence control of the Issuer during this period.  From time to time, Gordon received stock options pursuant to the Issuer’s compensation arrangements for non-employee directors.  Gordon was obligated to transfer any shares of Common Stock issued under any such stock options, or the economic benefit thereof, to the Reporting Persons, which in turn ensured that such shares or economic benefits were provided to the OrbiMed Funds.  Gordon stepped down from the Board of Directors in July 2017.

Item 7.

Materials to Be Filed as Exhibits